The Biden administration announced recently that the U.S. will no longer be in a COVID-19 emergency as of May 11, which means that an estimated five to 14 million Americans could lose access to health insurance via Medicaid.
The bill lowers healthcare costs, incentivizes companies to adopt renewable energies and produce clean energy products; provides consumer rebates for those products, and delivers tens of billions of dollars of direct investments to American communities—funded by taxes on billion-dollar corporations.
Two of Pennsylvania’s Republicans in the US House joined their Democratic colleagues in passing legislation to keep the cost of insulin at $35 a month.
The care Trump is likely to receive in the coming days will set him apart from most people who’ve contracted the virus, a disproportionate percentage of whom have been Black, Latino, or low-income.